These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34680938)

  • 21. Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1.
    Bagati A; Bianchi-Smiraglia A; Moparthy S; Kolesnikova K; Fink EE; Lipchick BC; Kolesnikova M; Jowdy P; Polechetti A; Mahpour A; Ross J; Wawrzyniak JA; Yun DH; Paragh G; Kozlova NI; Berman AE; Wang J; Liu S; Nemeth MJ; Nikiforov MA
    Cell Rep; 2017 Sep; 20(12):2820-2832. PubMed ID: 28930679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
    Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
    Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.
    Lüönd F; Tiede S; Christofori G
    Br J Cancer; 2021 Jul; 125(2):164-175. PubMed ID: 33824479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genomic alterations of invasive melanoma cells].
    Koroknai V
    Magy Onkol; 2022 Oct; 66(3):243-245. PubMed ID: 36200505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma.
    Shelton M; Anene CA; Nsengimana J; Roberts W; Newton-Bishop J; Boyne JR
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188456. PubMed ID: 33153973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance.
    Hossain SM; Eccles MR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
    Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
    Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
    Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
    Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.
    Fujita M; Norris DA; Yagi H; Walsh P; Morelli JG; Weston WL; Terada N; Bennion SD; Robinson W; Lemon M; Maxwell IH; Yohn JJ
    Melanoma Res; 1999 Jun; 9(3):279-91. PubMed ID: 10465584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.
    Gunarta IK; Li R; Nakazato R; Suzuki R; Boldbaatar J; Suzuki T; Yoshioka K
    Cancer Sci; 2017 Aug; 108(8):1602-1611. PubMed ID: 28635133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.
    Ghislin S; Deshayes F; Lauriol J; Middendorp S; Martins I; Al-Daccak R; Alcaide-Loridan C
    Melanoma Res; 2012 Jun; 22(3):184-94. PubMed ID: 22454190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasiveness-triggered state transition in malignant melanoma cells.
    Wang H; Zhang YG; Ma J; Li JC; Zhang J; Yu YQ
    J Cell Physiol; 2019 May; 234(5):5354-5361. PubMed ID: 30478974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.
    Taddei ML; Giannoni E; Morandi A; Ippolito L; Ramazzotti M; Callari M; Gandellini P; Chiarugi P
    Cell Commun Signal; 2014 Apr; 12():24. PubMed ID: 24690323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
    Vachtenheim J; Ondrušová L
    Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
    Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
    Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching.
    Lessard L; Liu M; Marzese DM; Wang H; Chong K; Kawas N; Donovan NC; Kiyohara E; Hsu S; Nelson N; Izraely S; Sagi-Assif O; Witz IP; Ma XJ; Luo Y; Hoon DSB
    J Invest Dermatol; 2015 Oct; 135(10):2464-2474. PubMed ID: 26016895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
    Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
    Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.